We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$39.7M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$34.3M
3
MRNA icon
Moderna
MRNA
+$29.3M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.3M
5
MTCH icon
Match Group
MTCH
+$9.52M

Top Sells

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$35.7M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
AAPL icon
Apple
AAPL
+$13.2M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$9.28M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$6.57M

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LORL
2026
DELISTED
Loral Space and Communications, Inc.
LORL
$220K ﹤0.01%
5,120
– –
ATRS
2027
DELISTED
Antares Pharma, Inc.
ATRS
$220K ﹤0.01%
60,369
+20,612
+52% +$83.3K
AKRO
2028
DELISTED
Akero Therapeutics
AKRO
$220K ﹤0.01%
9,830
– –
IGMS
2029
DELISTED
IGM Biosciences
IGMS
$219K ﹤0.01%
3,333
– –
MBI icon
2030
MBIA
MBI
$258M
$219K ﹤0.01%
17,028
+6,931
+69% +$80K
NWLI
2031
DELISTED
National Western Life Group, Inc. Class A
NWLI
$219K ﹤0.01%
1,039
– –
MGI
2032
DELISTED
MoneyGram International, Inc. New
MGI
$218K ﹤0.01%
27,211
– –
APR
2033
DELISTED
Apria, Inc. Common Stock
APR
$218K ﹤0.01%
+5,873
New +$193K
HLX icon
2034
Helix Energy Solutions
HLX
$1.49B
$218K ﹤0.01%
56,226
– –
PLBY icon
2035
Playboy Inc
PLBY
$150M
$218K ﹤0.01%
9,237
+4,309
+87% +$116K
UEIC icon
2036
Universal Electronics
UEIC
$68.5M
$217K ﹤0.01%
4,412
-1,616
-27% -$78.5K
GAN
2037
DELISTED
GAN Ltd
GAN
$217K ﹤0.01%
14,570
– –
BY icon
2038
Byline Bancorp
BY
$1.78B
$217K ﹤0.01%
8,821
+2,904
+49% +$69.3K
RAPT
2039
DELISTED
RAPT Therapeutics
RAPT
$216K ﹤0.01%
870
– –
ITOS
2040
DELISTED
iTeos Therapeutics
ITOS
$216K ﹤0.01%
7,999
– –
HVT icon
2041
Haverty Furniture Companies
HVT
$449M
$216K ﹤0.01%
6,403
– –
KROS icon
2042
Keros Therapeutics
KROS
$217M
$216K ﹤0.01%
5,456
– –
AMRX icon
2043
Amneal Pharmaceuticals
AMRX
$6.15B
$216K ﹤0.01%
40,405
– –
DBI icon
2044
Designer Brands
DBI
$314M
$216K ﹤0.01%
15,489
-6,420
-29% -$92.8K
ETD icon
2045
Ethan Allen Interiors
ETD
$584M
$216K ﹤0.01%
9,100
– –
CNR
2046
DELISTED
Cornerstone Building Brands, Inc.
CNR
$216K ﹤0.01%
14,751
-5,329
-27% -$86.6K
SLP icon
2047
Simulations Plus
SLP
$371M
$215K ﹤0.01%
5,451
– –
PAHC icon
2048
Phibro Animal Health
PAHC
$1.38B
$215K ﹤0.01%
9,993
– –
FDMT icon
2049
4D Molecular Therapeutics
FDMT
$603M
$215K ﹤0.01%
+7,979
New +$228K
DFTX
2050
Definium Therapeutics
DFTX
$6.02B
$215K ﹤0.01%
6,151
-2,244
-27% -$97K
80 81
82
83 84

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.